Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates.
about
Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori InfectionDifferent corrosive effects on hydroxyapatite nanocrystals and amine fluoride-based mouthwashes on dental titanium brackets: a comparative in vitro studyCoupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone HomeostasisBiological activity of lactoferrin-functionalized biomimetic hydroxyapatite nanocrystals.Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy.Fluoridated HAp:Ln3+ (Ln = Eu or Tb) nanoparticles for cell-imaging.Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs.Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma.Calcium-based biomaterials for diagnosis, treatment, and theranostics.Influences of mesoporous magnesium calcium silicate on mineralization, degradability, cell responses, curcumin release from macro-mesoporous scaffolds of gliadin based biocomposites.Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin.Effect of hydroxyapatite nanocrystals functionalized with lactoferrin in osteogenic differentiation of mesenchymal stem cells.Superparamagnetic iron-doped nanocrystalline apatite as a delivery system for doxorubicinBiomineralization of a titanium-modified hydroxyapatite semiconductor on conductive wool fibersPros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
P2860
Q27335157-381BD627-EBE2-4421-B151-240D241C65F0Q28393427-F673C4C1-AF02-4D18-B466-E01357B09C7BQ35684335-C383DD76-8B1E-402A-9D67-AD15BF00BE9EQ39015999-1708738E-0C40-4E3F-97A7-217EF92D1E2FQ39162597-36D6D27B-38E3-41C3-8C1F-72485C38F3FBQ39257336-8CD0C5F0-62E7-4E19-B5FB-C6D35C5ABE64Q39316883-3386EC66-C72C-4CDE-8FA2-D2CE2C03C2DAQ42829153-1215BB2B-DC32-47C7-B4A8-6E09EBC40D5AQ46924536-125E5B09-0025-47CC-9D9E-FA6997DCAEA4Q47231934-95A8952D-3ED1-4149-B56B-3EE51A67F53CQ47723958-DAC86C79-A5C4-4783-8F36-511295F8A7A7Q53778083-FBDBD565-32CB-4D7A-A425-167BC1B79DFAQ54217722-732D556B-268B-4FBA-8BFB-41F0607CA1DBQ57879972-FFA03D71-21F2-4623-B23A-7B7F2135BBD5Q58180146-665D31B6-D9A9-4826-93A4-18D0A6BACCA8Q59229081-34E1A694-1108-4FE0-BF59-1D58DBD33746
P2860
Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@en
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@nl
type
label
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@en
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@nl
prefLabel
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@en
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@nl
P2093
P2860
P50
P356
P1433
P1476
Nanocrystalline carbonate-apat ...... ncer platinum bisphosphonates.
@en
P2093
Cristina Marzano
Norberto Roveri
Sara Piccinonna
P2860
P304
P356
10.1039/C1NR11147G
P407
P577
2011-11-10T00:00:00Z